Apremax

Oral immunosuppressant, phosphodiesterase 4 (PDEA 4) indicated to treat moderate to severe plaque psoriasis and active psoriatic arthritis with inadequate response to other disease modifying drugs.

Therapeutic Area
Rheumatology + Dermatology + Psoriasis

Active Ingredient
Apremilast

Line
Dermatology + Oncology + Rheumatology

Pharmaceutical Forms
Starter kit:
10 mg tablets x 4
20 mg tablets x 4
30 mg tablets x 19
30 mg tablets x 30

Apremax 30 mg: 56 and 168 coated tablets

Download Prospectus Descargar